At a Glance
| General Manager, Dako Pathology | Britt Meelby Jensen |
| General Manager, Dako Reagent Partnership Division | Simon Østergaard |
Headquarters |
Produktionsvej 42 DK-2600 Glostrup Denmark +45 44 85 95 00 |
R&D and Production Sites |
Glostrup, Denmark Carpinteria, CA, USA |
Web Address |
www.dako.com |
Revenue |
DKK 1.9 billion (2012) |
Number of Employees |
Approx. 1,200 worldwide |
Ownership |
Dako is owned by Agilent Technologies www.agilent.com |
Area of Business |
Cancer Diagnostics: Dako has more than 45 years of experience within pathology and has played a pioneering role in the standardization of antibodies. Dako has grown into a well-established global company with a leading position in the pathology segment of the in vitro diagnostics (IVD) industry. Retail and OEM: Through Dako’s Reagent Partnership Division Dako manages and sells a comprehensive portfolio of specific proteins and high-quality reagents for flow cytometry. In addition to the retail portfolio, RP sell monoclonal and polyclonal antibodies as bulk solutions to OEM customers. |
| Products within: |
|
| History | Dako was founded by the Danish Medical Doctor Niels Harboe in 1966. Dako earned its reputation for innovation and quality by introducing the first conjugated antibodies for immunohistochemistry. |
Pharma partnerships |
|
